Prescription window for females of reproductive potential is 7 days beginning with the date of the pregnancy test specimen collection. Prescription window for females of non-reproductive potential and males is 30 days beginning with date of the office visit.

Prescriber Information

About Prescriber Information
The goals of the iPLEDGE Program are to prevent fetal exposure to isotretinoin and to inform prescribers, pharmacists, and patients about isotretinoin's serious risks and safe-use conditions. The resources below present the program requirements and help you prepare and plan treatments with patients during the course of isotretinoin therapy.

View Information Online
You can click on each link to view the material online. Upon clicking on a link, each file will be launched in a new browser window. To view these PDF files, you will need Acrobat® Reader®.

Manufacturer's Toll-free Numbers

For more information about the specific brands of isotretinoin, call the individual manufacturers at these numbers.

Product NameCompanyPhone Number
Amnesteem®Mylan Pharmaceuticals Inc.1-800-796-9526
Claravis®Teva Pharmaceuticals USA.1-800-227-7522
Sotret®Ranbaxy Laboratories, Inc.1-800-406-7984
Myorisan™VersaPharm Incorporated1-877-254-4381
Absorica™Ranbaxy Laboratories, Inc.1-800-406-7984
Zenatane™Dr. Reddy's Laboratories, Ltd.1-888-375-3784